Genes related to the very early stage of ConA-induced fulminant hepatitis: a gene-chip-based study in a mouse model by Chen, Feng et al.
Chen et al. BMC Genomics 2010, 11:240
http://www.biomedcentral.com/1471-2164/11/240
Open Access RESEARCH ARTICLE
BioMed  Central
© 2010 Chen et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Research article Genes related to the very early stage of 
ConA-induced fulminant hepatitis: a 
gene-chip-based study in a mouse model
Feng Chen1, Hai-Hong Zhu1, Lin-Fu Zhou2, Jie Li1, Li-Ying Zhao1, Shan-Shan Wu1, Jing Wang1, Wei Liu2 and Zhi Chen*1
Abstract
Background: Due to the high morbidity and mortality of fulminant hepatitis, early diagnosis followed by early effective 
treatment is the key for prognosis improvement. So far, little is known about the gene expression changes in the early 
stage of this serious illness. Identification of the genes related to the very early stage of fulminant hepatitis 
development may provide precise clues for early diagnosis.
Results: Balb/C mice were used for ConA injection to induce fulminant hepatitis that was confirmed by pathological 
and biochemical examination. After a gene chip-based screening, the data of gene expression in the liver, was further 
dissected by ANOVA analysis, gene expression profiles, gene network construction and real-time RT-PCR.
At the very early stage of ConA-triggered fulminant hepatitis, totally 1,473 genes with different expression variations
were identified. Among these, 26 genes were finally selected for further investigation. The data from gene network
analysis demonstrate that two genes, MPDZ and Acsl1, localized in the core of the network.
Conclusions: At the early stages of fulminant hepatitis, expression of twenty-six genes involved in protein transport, 
transcription regulation and cell metabolism altered significantly. These genes form a network and have shown strong 
correlation with fulminant hepatitis development. Our study provides several potential targets for the early diagnosis of 
fulminant hepatitis.
Background
Fulminant hepatitis mainly develops from chronic or
acute hepatitis B virus (HBV) infection. It has been
reported that world widely about 400 million people are
living with chronic HBV infection. While 500,000 people
die from HBV-related liver cirrhosis and hepatocellular
carcinoma, acute fulminant hepatitis B causes additional
40,000 deaths each year[1].
Despite the significant improvement in the antiviral
treatment targeting HBV infection, the morbidity and
mortality of fulminant hepatitis keep at a high level. This
is at least partly due to our poor understanding of the
pathogenesis of the disease and the lack of early diagnos-
ing/warning system which lead to a delayed medical
intervention. As a serious illness, fulminant hepatitis is
not only a threat to our health, but a big financial burden
to the patient's family. Therefore, an accurate diagnosis at
an early stage is linked directly to an effective treatment,
better recovery and lowered mortality of the disease.
Because it resembles very much the human fulminant
hepatitis, concanavalin A (ConA)-induced hepatitis has
long been used as an e x perimental mode l of imm une-
mediated liver disease [2]. It is characterized by massive
hepatocellular degeneration and lymphoid infiltration of
the liver [3]. The development of ConA-induced hepatitis
depends mainly upon T cell activation [4] which raises
plasma levels of various cytokines including TNF-α,
interferon (IFN)-γ, and interleukin (IL)-6 [5]. To investi-
gate the pathogenic mechanism of human fulminant hep-
atitis, in this study, we utilized the ConA-induced
hepatitis model and selected microarray as our primary
detection tool.
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Recently, high-throughput gene chip has increasingly
been used to explore the transcription dynamics on a
genome-wide scale. This raises a possibility that similar
approach could be used to identify gene expression at a
specific condition such as the very early stage of fulmi-
nant hepatitis. Then the alternations in gene expression
could possibly be used as diagnostic measures. Given this
aim, it is necessary to use statistical methods to help iden-
tify genes whose transcript profiles respond to liver dam-
age. In addition, such approach involves modeling the
association of a generic response with a specific experi-
mental variable, such as timing, tissues impacted, tem-
perature, or drug dosage. Therefore, whole genome
expression analysis provides a system-level insight for
understanding crucial factors that control the liver dam-
age and in turn may help us elucidate the molecular
mechanisms of liver injury.
In this study, by using the ConA-induced mouse fulmi-
nant hepatitis model, we analyzed the hepatic gene
expression with whole genome mouse GeneChip
(Affymetrix). Through an integrative analysis that com-
bines changes in gene expression with gene function
within a genetic network, we identified 26 genes that may
be related to ConA-induced liver injury.
Results
ConA-injection induces fulminant hepatitis in Balb/C mice
Pathological examination at indicated time periods after
ConA challenge showed that fulminant hepatitis mouse
model was successfully made. As shown in Figure 1, a sin-
gle injection of ConA led to a clear liver damage as pre-
sented by large area of necrosis (Figure 1). In order to
study the changes of very early stage of fulminant hepati-
tis, liver specimen were taken from the mice at 1 h, 3 h,
and 6 h after ConA administration for the further investi-
gation.
Biochemical evidence for ConA-induced hepatitis
To observe the liver damage in our ConA-induced hepati-
tis model, we measured by using the classical Reitman-
Frankel method the serum levels of alanine aminotrans-
ferase (ALT), aspartate aminotransferase(AST), serum
total bilirubin (STB) and serum lactate dehydrogenase
(LDH). See details in Table 1.
Genes screened by Gene-chip study
Genome-wide transcriptional profiling of the liver has
demonstrated that extensive gene expression occurs dur-
ing very early-stage fulminant hepatitis. To investigate
the possible gene expression change in our ConA-
induced hepatitis model at a very early stage, we per-
formed a gene chip study by using the Affymetrix probe
dataset which includes totally 45101 probes. We found
when compared with probes in the control group, 1559
probes increased and 1794 probes decreased in the 1 h
group, 3040 probes increased and 4160 probes decreased
in the 3 h group, and 5466 probes increased and 5445
probes decreased in the 6 h group. Our data indicate that
by time after ConA injection more and more gene expres-
sion is detectable. The in detail gene expression data are
also available at the GEO website under accession num-
ber GSE17184: http://www.ncbi.nlm.nih.gov/geo/
Genes further screened by ANOVA and model profile 
analysis
ANOVA corrected with the randomized variance model
was performed to determine genes that were expressed
separately and differentially. As a result, total 1,473 genes
that had a p-value and the false discovery rate (FDR) less
than 0.05 were declared to be significantly expressed. The
gene expression value per group was the geometric mean
of the Robust Multichip Average (RMA) normalized gene
signals of 3 samples per time point.
To further narrow the target genes which harbor great
significance among the declared 1,473 genes, we chose to
use the twenty-six model profiles to summarize the
expression pattern of the genes. As shown in Figure 2,
among the 26 patterns, we identified 10 patterns of genes
that shown very significant p-values (colored boxes).
Among these patterns, the two most significant pat-
terns were profiles No. 9 and No.16 according to ascend-
ing p-values. While the profile No. 16 contained 118
genes whose expression increased constantly, the profile
No. 9 contained 209 genes whose expression reduced
constantly, after ConA injection (Figure 3).
Figure 1 Pathological examination of liver in mice model with 
fulminant hepatitis induced by ConA-injection. ConA induced ful-
minant hepatitis was confirmed by using pathological examination. 
Mice liver tissue was obtained at indicated time periods and stained 
with haematoxylin and eosin. ConA caused pathological changes in 
mice liver after ConA challenge from the photomicrographs present-
ed. Necrosis appeared at 12 h after ConA administration and the sever-
ity of necrosis increased with the time. A large area of necrosis was 
found at 72 h after ConA injection.
72h  24h 
12h  6hChen et al. BMC Genomics 2010, 11:240
http://www.biomedcentral.com/1471-2164/11/240
Page 3 of 11
26 genes identified by Gene Co-expression Network with k-
core algorithm from profiles No.9 and No. 16
Genes in profiles No.9 and No.16 were then analyzed and
identified by gene co-expression network with k-core
algorithm to determine which gene or genes may play
pivotal role in the early stage of fulminant hepatitis. Gene
networks are constructed from functional gene associa-
tions. In the network, cycle nodes represent genes, and
edges between two nodes represent interactions between
genes, which were quantified by degree. Degrees within
the network which describe the number of single gene
that regulates other genes represent the size of the cycle
node. The higher the degree, the more central the gene
occurs within the network. The clustering coefficient can
be used to estimate the complexity of interactions among
genes that neighbor the core gene with the exception of
core gene participation. The lower the clustering coeffi-
cient, the more independent of the core gene are the
Table 1: The ALT, AST, STB and LDH levels in mouse serum after ConA administration
ALT AST STB LDH
Control group 38.33 ± 1.53 85.33 ± 4.04 2 ± 0 832.67 ± 94.00
1 h 64.67 ± 7.51Δ 194.67 ± 60.90Δ 3.67 ± 0.58Δ 980.0 ± 197.38
3 h 66.67 ± 12.50Δ 222.38 ± 113.40 3 ± 1.00 2454.78 ± 198.62
6 h 1068.17 ± 418.08 768.0 ± 729.61Δ 4.83 ± 0.60Δ 3514.33 ± 977.57Δ*
ΔCompared with control, P < 0.05, *compared with 1 h, P < 0.05
The serum markers of liver injury, such as ALT, AST, STB and LDH, increased with time after ConA injection. Compared with normal control, 
ALT and STB increased at 1 h by 1.7-fold and 1.8-fold respectively, and ALT, AST, STB and LDH level at 6 h increased by 27.9-fold, 9.0-fold, 2.4-
fold and 4.2-fold, respectively.
Figure 2 The expression patterns of 1,473 genes analyzed by model profile. The expression patterns of 1,473 genes were analyzed and twenty-
six model profiles were used to summarize. Each box represents a model expression profile. The upper number in the profile box is the model profile 
number and the lower one is the p-value; Ten expression patterns of genes showed significant p-values (p < 0.05) (colored boxes)Chen et al. BMC Genomics 2010, 11:240
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interactions among genes in the neighborhood of the
core gene[6].
A k-core of a gene co-expression network usually con-
tains cohesive groups of genes. On the other hand, phylo-
genetic analysis classifies genes into groups based on the
similarity of base sequences[7].
The k-core subnetwork with higher k-core level in our
result is considered to have a core status within a large-
scale gene network made up of differential 26 genes (see
Figure 4 and Table 2). Most of the genes are attributed to
transport, transcription, regulation of transcription, met-
abolic processes, and carbohydrate metabolic processes,
consistent with the gene ontology hierarchical category,
lipoprotein catabolic processes, peptide biosynthetic pro-
cesses, positive regulation of calcium-dependent cell-cell
adhesion, fructosamine metabolic processes, male sex
differentiation, and regulation of cholesterol biosynthesis.
The core genes MPDZ and ACSL1 appear at the center of
both the large-scale network and the 11 k-core subnet-
work. They directly regulate 34 neighboring genes that
interact according to their degrees. These interactions
depend in large part on MPDZ and ACSL1 because the
clustering coefficients of these genes are 0.38 and 0.42,
which are lower than for other genes.
In this network, transmembrane proteins, such as
MPDZ and Acsl1, were shown to play a role in the impor-
tant processes of cell adhesion, carbohydrate metabolism
and molecular transport. However, MPDZ expression
constantly decreased over the four time points. It may
contribute to damage to cell junctions in liver cells. The
result of MPDZ down expression may be related to disor-
ders of liver tissue and may lead to obstacles in the carbo-
hydrate metabolic process. Acs11 was an essential gene
that was associated with long-chain-fatty-acid-CoA syn-
thase activity. The under expression of the gene gives rise
to a series of obstructions in lipid and cholesterol biosyn-
thetic and metabolic processes.
Real-time RT-PCR verification of the genes
Real-time RT-PCR was used to confirm the expression of
the 26 genes. Compared with normal controls, the
expression of most of the 26 genes showed a statistical
significant change (p < 0.05). Expressions of PARD3,
ALDH8A1, CMTM8 and FBXO3 were also higher than
those of normal controls, but there was no statistical sig-
nificance (p > 0.05) (See details in Table 3 and the primers
see in Additional file 1).
Discussion
In this study, use of a fulminant hepatitis mouse model,
we have focused on hepatic gene expression during early
stages of fulminant hepatitis. By a series of biological and
bioinformatics analysis, we identified 26 genes whose
expression are significantly altered at the very early stage
and have shown big correlations with fulminant hepatitis.
Using gene chips has the advantage of generating huge
amounts of information. The high cost of microarray
experiments and limited sample availability resulted in a
small sample size for each treatment group. In addition,
because we had to filter differential genes, our two-group
comparison accuracy was reduced because variance esti-
mates have few degrees of freedom. Consequently, we
obtained results with more power and less variation by
Figure 3 Gene expression of profile No.9 and No. 16 in the context of significant ConA-induced liver injury. The profile No.9 (A) contained 209 
genes and they decreased in expression consistent with prolonged liver damage after injecting ConA. The profile No.16 (B) had 118 genes and they 
increased in expression consistent with prolonged liver damage after the injection. These processes may indicate that the assigned genes closely cor-
relate with the results of regulatory gene expression, including activation and inhibition in the context of liver damage caused by ConA challenge. 
The horizontal axis represents time, and the vertical axis shows the time series of gene expression levels for the gene after Log normalized transfor-
mation.
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using the random variance model corrected standard t-
test or ANOVA methodology [8].
We predefined certain sets of profiles in the context of
patterns that can be expected in the course of growth. On
account of the noise and the small number of points for
each gene, any one pattern will be shared by many genes
a n d  c a n  b e  e x p e c t e d  t o  a p p e a r  b y  c h a n c e .  F i r s t ,  w e
selected a set of potential expression profiles. These sets
of profiles cover all of the possible profiles that can be
generated by gene expression in the course of growth, and
each represents a single temporal expression pattern.
Enrichment of genes in each profile was then used to
measure the profile significance level. Significant profiles
may indicate that there were mostly common functions
attributed to genes that are co-expressed. Such functions
mainly influence the biological character [9].
In biological processes, macromolecular networks can
be constructed by the experience results from such as Y-
2H, and coimmunoprecipitation, or from the algorithmic
predict base on the gene function correlation and expres-
sion profiles. Because of the flexibility of the network
model base on the algorithmic predict from high
throughput gene expression tests, we can look at snap-
shots of protein-protein interaction, gene expression reg-
ulatory networks and metabolism networks among
different groups. The intrinsic gene networks of a pheno-
type can represent gene function propriety of sample. k-
cores and degrees of genes are key attributes in the net-
work. A k-core of a network is a subgraph in which all
genes are connected to at least k other genes in the sub-
graph [6]. In a protein-protein interaction network, a
node represents a protein and an edge represents an
interaction between proteins. In this work, we use k-cores
Figure 4 Gene co-expression network. Genes from profiles No.9 and No.16 were analyzed and identified by gene co-expression network with k-
core algorithm. Cycle nodes represent genes, the size of nodes represents the power of the interrelation among the nodes, and edges between two 
nodes represent interactions between genes. The more edges of a gene, the more genes connecting to it, the more central role it has within the net-
work.
 Chen et al. BMC Genomics 2010, 11:240
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Table 2: 26 genes identified by gene co-expression network with k-core algorithm
Gene symbol Clustering Coefficient Degree k-core
ACSL1 0.418894827 34 11
ALDH8A1 0.489230782 26 11
CAR5A 0.589473665 20 11
CMTM8 0.464615375 26 11
FASTKD1 0.594736814 20 11
FBXO3 0.467980295 29 11
GPD1L 0.637426913 19 11
HLF 0.757352948 17 11
KLB 0.608187139 19 11
MAP2K6 0.70588237 17 11
MPDZ 0.377896607 34 11
MSRB2 0.509803951 18 11
MTAP 0.608333349 16 11
ORMDL1 0.430107534 31 11
PARD3 0.619047642 15 11
PDE7B 0.486166 23 11
POLG2 0.565217376 23 11
SLC29A1 0.393548399 31 11
SOX5 0.492307693 26 11
STARD5 0.666666687 15 11
TERT 0.452631593 20 11
COLEC11 0.494505495 14 10Chen et al. BMC Genomics 2010, 11:240
http://www.biomedcentral.com/1471-2164/11/240
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of protein-protein interaction networks to define main
gene function in main subgraph. The rank of k-core value
describes the complexity of gene association relationship.
The complexity of gene relationship increased with k-
core value rank. We wanted to find main Gene Ontology
(GO) assigned by the maximum numbers of genes in sep-
arately k-core and then define the key gene functions at
each complexity level of network [7]. For this analysis
result, we conclude the core functions at the core status
of network which have a top k-core level.
Regulation of gene expression as well as protein-protein
interactions can change in a dynamic process over time.
Such processes may exhibit a regulatory character. These
macromolecular networks respond to the events such as
growth, metabolism, and apoptosis. Because certain gene
interactions are only observable under very specific con-
ditions, we combined experimental data to model co-
expression networks from different types of experiments.
One of the important reasons for doing this was the fact
that differential macromolecular network structures have
different sources. In this study, twenty-six genes were
selected using the network, and validated by Real-time
RT-PCR. Compared with normal controls, the expression
of most of the 26 genes appeared a statistical significant
change (p < 0.05).
A very important issue about the results from a gene-
chip-based analysis is their correlation to the actual bio-
logical processes. Many of the 26 genes identified in this
study including MPDZ and ACSL1 are involved in the
metabolism of liver cells. Although the expression of
these genes may not be specifically initiated or sup-
pressed by fulminant hepatitis, the emergence or inhibi-
t i o n  o f  t h e  g e n e s  a t  t h e  v e r y  e a r l y  s t a g e  o f  f u l m i n a n t
hepatitis could be followed by severe liver damage, the
pathological hallmark of fulminant hepatitis presented as
large area of necrosis, thereby supplying potential diag-
nostic information for clinical fulminant hepatitis. In this
study, we employed a ConA-induced animal fulminant
hepatitis model instead of the use of human tissue which
is extremely tough to obtain. As mentioned earlier,
ConA-induced hepatitis has broadly been used as an
experimental model of immune-mediated liver disease.
Our pathological and biochemical data further confirmed
that the model resembles very much the human fulmi-
nant hepatitis. Therefore, our results may provide impor-
tant referential merit for clinical investigation.
Nevertheless, in all conscience, the genes identified here
are required to be further dissected and confirmed in
human by other clinic-related studies.
Conclusions
At the early stages of fulminant hepatitis induced by
ConA, expression of twenty-six genes involved in protein
transport, transcription regulation and cell metabolism
altered significantly. These genes form a network and
have shown strong correlation with fulminant hepatitis
development and a promising future for early diagnosis.
Our study provides several potential targets for the early
diagnosis of fulminant hepatitis in clinical scenario.
Methods
Animals
Eight- to 10-week-old male Balb/C mice were purchased
from the Animal Center, Zhejiang Academy of Medical
Sciences. The average weight was 25 g. All mice were
kept at least 1 wk at 22°C and 55% relative humidity in a
12-h day/night lighting environment with free access to
food and water. The animals were raised and cared for in
accordance with guidelines established by the National
Science Council of the Republic of China.
ConA administration
Mice were given a tail vein injection of ConA (Sigma
Chemical Co., St. Louis, MO) in 100 μl PBS at a concen-
tration of 20 mg/kg, and same dose of PBS was used as
negative control.
DPP4 0.495238096 15 10
CDH2 0.561904788 15 9
COLEC12 0.604395628 14 9
FN3K 0.551282048 13 9
Degrees describe the number of single gene that regulates other genes represent the size of the cycle node. The higher the degree, the more 
central the gene occurs within the network. The clustering coefficient can be used to estimate the complexity of interactions among genes 
that neighbor the core gene with the exception of core gene participation. The lower the clustering coefficients, the more independent of 
the core gene are the interactions among genes in the neighborhood of the core gene. A k-core of a gene co-expression network usually 
contains cohesive groups of genes. The higher the k-core, the more central the genes occurs within the network. In this study, the top k-value 
is 11, which is considered to have a core status within a large-scale gene network made up of differential genes from profiles No.9 and No. 16.
Table 2: 26 genes identified by gene co-expression network with k-core algorithm (Continued)Chen et al. BMC Genomics 2010, 11:240
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Table 3: The expression of 26 genes in the very early stage of fulminant hepatitits mice model by real-time RT-PCR
genes Number ΔΔct (1 h/
control)
ΔΔct (3 h/
control)
ΔΔct (6 h/
control)
ΔΔct (12 h/
control)
ACSL1 12 1.58 ± 1.72 2.21 ± 3.81 0.47 ± 0.55# 0.71 ± 1.46
ALDH8A1 12 1.26 ± 0.62 5.16 ± 9.96 16.47 ± 40.57 2.78 ± 3.74
CMTM8 12 4.24 ± 5.47 60.46 ± 127.18 48.60 ± 111.88 62.93 ± 106.90
COLEC11 12 0.73 ± 0.29# 4.04 ± 2.35#* 3.27 ± 4.40 1.50 ± 2.00&
COLEC12 12 1.19 ± 0.54 3.86 ± 3.41#* 2.44 ± 2.77 6.59 ± 12.03
DPP4 12 0.87 ± 0.60 11.64 ± 6.76#* 14.91 ± 14.25#* 86.16 ± 218.29
FBXO3 12 1.79 ± 1.59 2.13 ± 1.91 1.64 ± 1.54 1.09 ± 0.72
FN3K 12 1.60 ± 1.98 3.38 ± 2.88# 2.01 ± 1.96 2.20 ± 3.57
GPD1L 12 2.61 ± 3.59 0.76 ± 0.83# 0.35 ± 0.30# 1.25 ± 3.02
HLF 12 1.49 ± 1.39 8.15 ± 10.11*# 4.26 ± 5.27 3.72 ± 5.31
KLB 12 1.01 ± 0.51 1.93 ± 1.11*# 2.93 ± 5.05 1.58 ± 1.91
MAP2K6 12 2.61 ± 1.75# 31.29 ± 90.44 0.94 ± 1.188* 1.40 ± 2.07
MPDZ 12 3.02 ± 2.23# 6.28 ± 4.92# 3.96 ± 5.98 5.11 ± 6.11
MTAP 12 1.77 ± 0.74# 11.75 ± 31.48 3.81 ± 8.55 1.56 ± 1.56
MSRB2 12 1.77 ± 1.60 7.07 ± 5.81#* 2.38 ± 2.35& 3.34 ± 3.52#
ORMDL1 12 1.15 ± 0.91 2.85 ± 1.81#* 1.57 ± 0.86& 1.23 ± 0.50&
POLG2 12 0.71 ± 0.51 5.74 ± 9.951 3.07 ± 3.28* 1.46 ± 0.84*
STARD5 12 1.39 ± 1.20 2.58 ± 5.52 2.09 ± 2.91 2.52 ± 1.03#*
PARD3 12 1.24 ± 1.50 6.74 ± 11.47 3.83 ± 4.79 2.05 ± 2.39
SLC29A1 12 0.82 ± 0.44 1.75 ± 1.35* 1.16 ± 1.71 0.33 ± 0.29#*&
SOX5 12 0.91 ± 0.65 1.56 ± 0.63#* 0.85 ± 0.52& 3.25 ± 3.84Chen et al. BMC Genomics 2010, 11:240
http://www.biomedcentral.com/1471-2164/11/240
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Histology
The livers were removed, and part of each liver was fro-
zen in liquid nitrogen, while another part was fixed with
4% phosphate-buffered paraformaldehyde and embedded
in paraffin. Tissue sections (4 μm) were prepared and
stained with hematoxylin/eosin; sections were then
examined under light microscopy.
Biochemical detection
The extent of liver injury was assessed by determining
serum ALT, AST, STB and LDH activity levels using the
standard Reitman-Frankel method.
Isolation of RNA
Liver samples from very early stage of fulminant hepatitis
mouse model, which include control group, 1 hour 3
hours and 6 hours after the injection of ConA, were
ground into a fine powder in a mortar cooled by liquid
nitrogen, and 100 mg was added to 1 ml prechilled Trizol
reagent (Invitrogen, Carlsbad, CA). Total RNA extrac-
tions were performed according to the manufacturer's
directions, and the RNA was further purified by passage
through RNeasy mini-columns (QIAGEN, Valencia, CA)
according to the manufacturer's protocols for RNA clean-
up. Final RNA preparations were resuspended in RNase-
free water and stored at -80°C. The RNA samples were
quantified spectrophotometrically, and purity and integ-
rity were assessed by agarose gel electrophoresis. All sam-
ples exhibited 260/280 absorbance ratios of
approximately 2.0, and all showed intact ribosomal 28S
and 18S RNA bands in an approximate ratio of 2:1 as
visualized by ethidium bromide staining.
First-Strand cDNA Synthesis
Total RNA (1 μg to 15 μg) and 2 μL of 50 μM T7-Oligo
(dT) Primer were mixed together in a 0.2 mL PCR tube,
and RNase-free water was added to create a final volume
of 12 μL. The tubes were gently flicked a few times to mix
the solution, and then the tubes were briefly centrifuged
to collect the reaction products and reagents at the bot-
tom of the tube. The reaction was incubated for 10 min-
utes at 70°C. The sample was cooled at 4°C for at least 2
minutes. Subsequently, 4 μL of 5× 1st Strand Reaction
Mix, 2 μL of 0.1 M DTT, 1 μL of 10 mM dNTP, were com-
bined and mixed thoroughly by flicking the tube a few
times. The tubes were centrifuged briefly to collect the
reaction products and reagents at the bottom of the tube,
and the tubes were immediately placed in a 42°C environ-
ment. SuperScript II (1 μL) was added to each RNA sam-
ple for a final volume of 20 μL. The RNA was incubated
for 1 hour at 42°C; finally, the sample was cooled for at
least 2 minutes at 4°C.
Second-Strand cDNA Synthesis
RNase-free water 91 μL, 30 μL of 5× 2nd Strand Reaction
Mix, 3 μL of 10 mM dNTP, 1 μL of E. coli DNA ligase, 4
μL of E. coli DNA Polymerase I, and 1 μL of RNase H
were mixed by gently flicking the tube a few times. The
tubes were centrifuged briefly to collect solids at the bot-
tom of the tube. We added 20 μL of the First-Strand
cDNA synthesized as described above. The tube was
flicked gently a few times to mix the solution, and then
the samples were centrifuged briefly to collect any reac-
tion products and reagents at the bottom of the tube. The
cDNA was incubated for 2 hours at 16°C. 2 μL of T4 DNA
Polymerase was added to each sample, and the tubes were
TERT 12 0.82 ± 0.70 2.71 ± 2.52#* 1.89 ± 2.55 1.09 ± 2.22
CAR5A 12 1.87 ± 2.61 2.56 ± 3.16 0.54 ± 0.57# 0.45 ± 0.63#&
FASTKD1 12 0.38 ± 0.26# 1.75 ± 1.35* 0.95 ± 0.50* 0.46 ± 0.30#&
PDE7B 12 0.64 ± 0.40# 1.39 ± 2.18 0.44 ± 0.33# 0.59 ± 0.33#
FASTKD1 12 0.96 ± 0.96 1.90 ± 1.04#* 0.63 ± 0.44#& 0.60 ± 0.49#&
#: Compared with 0 h, the difference was significant (p < 0.05)
*: Compared with 1 h, the difference was significant (p < 0.05)
&: Compared with 3 h, the difference was significant (p < 0.05)
: Compared with 6 h, the difference was significant (p < 0.05)
Compared with normal controls, the expression of most of the 26 genes showed a statistical significant change (p < 0.05). Expressions of 
PARD3, ALDH8A1, CMTM8 and FBXO3 were also higher than those of normal controls, but there was no statistical significance (p > 0.05)
Table 3: The expression of 26 genes in the very early stage of fulminant hepatitits mice model by real-time RT-PCR (Continued)Chen et al. BMC Genomics 2010, 11:240
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incubated for 5 minutes at 16°C. Finally, we added 10 μL
of 0.5 M EDTA.
Microarrays
The biotinylated cDNAs were hybridized to 12 individual
Affymetrix GeneChips Mouse 430 2.0 Arrays (Affyme-
trix, Inc., Santa Clara, CA). This product analyzes the
expression level for over 39,000 transcripts and variants,
including over 34,000 well-substantiated mouse genes.
Data Analysis
Significant Differential Gene Analysis
The per-group gene expression value was the geometric
mean of RMA normalized gene signals from 3 samples
per time point. Due to the fact that the number of sam-
ples per class (i.e., three samples per group) was far lower
than the number of genes, there were few degrees of free-
dom for the gene expression signal variance. The low
number of degrees of freedom makes an accurate estima-
tion of variability difficult. Significant differential genes
among the three groups were filtered by ANOVA and
corrected by the random variance model (RVM)[8]. In
this experiment, the differential genes from different time
points were filtered by RVM ANOVA. To assess the sig-
nificance of a particular sample having occurred by ran-
dom chance, the false discovery rate (FDR) was estimated
to allow us to determine whether certain genes were actu-
ally significant by repeating the comparison test and the
permutation test 1000 times. The threshold of truly sig-
nificant genes was taken to be p-value < 0.05 and FDR <
0.05.
Time Sequence Profile Analysis of Gene Expression
We first select a set of distinct and representative tempo-
ral expression profiles independent of the data. These
model profiles correspond to possible profiles of a gene's
change in expression over time. Passing the data normal-
ization  ( , , ,  and ),
each gene is assigned to the model profile that most
closely matches the gene's expression profile as deter-
mined by the correlation coefficient. Since the model
profiles were selected independent of the data, the algo-
rithm can then determine which profiles have a statisti-
cally significant higher number if genes assigned using a
permutation test. This test determines an assignment of
genes to model profiles using a large number of permuta-
tions of the time points. It then uses standard hypothesis
testing to determine which model profiles have signifi-
cantly more genes assigned under the true ordering of
time points compared to the average number assigned to
the model profile in the permutation runs. Significant
model profiles can either be analyzed independently, or
grouped together based on similarity to form clusters of
significant profiles.
Construction and Topological Analysis of the Gene Co-
Expression Network
In biological processes, macromolecular networks can be
constructed by using results from experiments involving
Y-2H, coimmunoprecipitation [10], or algorithmic pre-
dictions that may be based on gene function correlation
and expression profiles [11]. Because of the flexibility of
network models based on algorithmic predictions that
derive from high-throughput gene expression tests, we
can look at snapshots of protein-protein interactions,
gene expression regulatory networks and metabolic net-
works among different groups [12]. Gene networks are
constructed from functional gene associations. In the
network, cycle nodes represent genes, and edges between
two nodes represent interactions between genes. As net-
work elements represent the ways in which genes may
regulate other genes, large scale gene networks can be
divided into certain subgraphs, named k-core networks,
in which all genes are connected to at least k other genes
in the subgraph [7]. As a result, the rank of k-core value
describes the complexity of the gene association relation-
ship. Cycles with identical colors are part of the same
subgraph. In light of the definition of k-core networks,
core status within large scale gene networks consists of
subgraphs that are associated with higher k values. The
complexity of gene relationships increases with k-core
value rank. The intrinsic gene network of a given pheno-
type can represent gene function propriety within a sam-
ple. In this work, we use k-cores of protein-protein
interaction networks to define major gene functions in
the main subgraph. We wanted to identify the main GO
on the basis of the maximum number of genes in separate
k-cores and then we wished to define the key gene func-
tions at each complexity level of the network [13]. We
transformed the normalized expression value of the Pear-
son correlation into measures of pairwise connection
strengths [12]. We selected genes from the two most sig-
nificant profiles, namely profiles 9 and 16, to construct a
co-expression network. The network edges were speci-
fied to feature correlation coefficients of above 0.9, to
ensure strong gene co-expression relationships. The cen-
trality of the network is represented by the central degree
[6]. It is possible to identify characteristic distance vari-
ables among genes. We attempted to describe the contri-
log 2 0
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h
h log 2 1
0
h
h log 2 3
0
h
h log 2 6
0
h
hChen et al. BMC Genomics 2010, 11:240
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bution that gene i makes to the status (i.e., the
determining central status) of gene j in the network. The
maximum core order is termed the main core or the high-
est k-core of the graph[7]. A k-core subgraph can be gen-
erated by recursively deleting the vertices from a graph
whose degree is less than k [7]. Larger values clearly cor-
respond to vertices with larger degrees and more central
positions in the network structure. In this work, we apply
the notion of k-core subgraphing to predict gene function
similarity [13]. The nodes labeled by the same color may
represent similar gene ontology terms. The highlighted
ontologies of same-colored nodes were assessed by
counting genes that featured the same gene ontology and
the same color.
Real-time RT-PCR confirmation of differentially expressed 
genes
Real-time RT-PCR was used to verify the differential
expression of twenty-six genes that were detected by the
Affymetrix GeneChip. The primers used are listed in
Additional file 1. Each real-time RT-PCR reaction (in 25
μL) contained 2×SYBR Green Realtime PCR Master Mix,
0.4 μM primers, and 0.5 μL of template cDNA. The
cycling conditions consisted of an initial, single cycle of 5
min at 95°C, followed by 40 cycles of 30 sec at 95°C, 30
sec at 54°C, 15 sec at 72°C, and fluorescence acquisition
at 83°C for 1 sec. The cDNA was synthesized using
reverse transcriptase (Promega), oligo(dT) and random
primers with 5 μg RNA from the same samples as those
used in the microarray. The PCR amplifications were per-
formed in duplicate for each sample. The gene expression
levels were quantified relative to the expression of β-actin
by employing an optimized comparative Ct (ΔΔCt) value
method. The differences in gene expression levels
between groups were compared using the Student's t-test.
A p value < 0.05 was considered significant.
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